BioWorld

March 24, 2006

View Archived Issues

Pfizer Licenses, Invests In Noxxon’s Spiegelmer Drugs

Since its founding in 1997, German company Noxxon Pharma AG has flown low, working to develop products based on its Spiegelmer technology. (BioWorld Today) Read More

CombinatoRx Privately Raises $48M For Pipeline Of Phase IIs

Read More

New Method Tests If H5N1 Can Learn How To Spread

Read More

Quaker BioVentures: Southeast Will Be Next Big Biotech Region

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

Clinic Roundup

Read More